These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18981309)

  • 21. Vascular disease in rheumatoid arthritis: from subclinical lesions to cardiovascular risk.
    Tanasescu C; Jurcut C; Jurcut R; Ginghina C
    Eur J Intern Med; 2009 Jul; 20(4):348-54. PubMed ID: 19524171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ileostomy and ramipril-induced acute renal failure and shock.
    Chen JP
    Heart Lung; 2007; 36(4):298-9. PubMed ID: 17628199
    [No Abstract]   [Full Text] [Related]  

  • 23. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study.
    Stamatelopoulos KS; Kitas GD; Papamichael CM; Chryssohoou E; Kyrkou K; Georgiopoulos G; Protogerou A; Panoulas VF; Sandoo A; Tentolouris N; Mavrikakis M; Sfikakis PP
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1702-8. PubMed ID: 19608975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition.
    Neutel JM
    Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pace-maker syndrome].
    Pfister R; Hoppe UC
    Dtsch Med Wochenschr; 2008 Mar; 133(12):575-6. PubMed ID: 18335384
    [No Abstract]   [Full Text] [Related]  

  • 26. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G; Salehian O; Yi Q; Healey J; Mathew J; Al-Merri K; Al-Nemer K; Mann JF; Dagenais G; Lonn E;
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of renin-angiotensin system blockade in patients with diabetes mellitus.
    Braga MF; Leiter LA
    Am J Cardiol; 2009 Sep; 104(6):835-9. PubMed ID: 19733720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Not Available].
    Füessl HS
    MMW Fortschr Med; 2013 May; 155(10):34. PubMed ID: 23930415
    [No Abstract]   [Full Text] [Related]  

  • 29. Neutrophil hypersegmentation in children receiving angiotensin converting enzyme inhibitors.
    Okutan V; Kürekçi AE; Sarici SU; Atay AA; Yozgat Y; Azik F; Lenk MK; Ozcan O
    Turk J Pediatr; 2008; 50(5):438-42. PubMed ID: 19102047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload.
    Müller P; Kazakov A; Jagoda P; Semenov A; Böhm M; Laufs U
    Cardiovasc Res; 2009 Jul; 83(1):106-14. PubMed ID: 19380417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of vasculitis in rheumatoid arthritis: comment on the article by Turesson et al.
    Puéchal X
    Arthritis Rheum; 2005 May; 52(5):1620; author reply 1621. PubMed ID: 15880350
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin-converting enzyme inhibitors in patients with vascular disease.
    Pitt B
    Eur Heart J; 2009 Jun; 30(11):1307-9. PubMed ID: 19383733
    [No Abstract]   [Full Text] [Related]  

  • 33. Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: comment on the article by Rudominer et al.
    Vizzardi E; Cavazzana I; Ceribelli A; Tincani A; Dei Cas L; Franceschini F
    Arthritis Rheum; 2009 Sep; 60(9):2852-3. PubMed ID: 19714624
    [No Abstract]   [Full Text] [Related]  

  • 34. Decrease over time in the incidence of systemic rheumatoid vasculitis: Comment on the article by Turesson et al.
    Watts RA; Lane SE; Scott DG
    Arthritis Rheum; 2005 May; 52(5):1620-1; author reply 1621. PubMed ID: 15880813
    [No Abstract]   [Full Text] [Related]  

  • 35. Smoking and rheumatoid arthritis: comment on the letter by McDonagh and Walker.
    Masi AT; Fecht T; Aldag JC; Malamet RL; Hazes JM
    Arthritis Rheum; 1998 Jan; 41(1):184-5. PubMed ID: 9433888
    [No Abstract]   [Full Text] [Related]  

  • 36. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].
    Alhadad A; Sterner G; Herlitz H
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2836-8, 2840. PubMed ID: 19967962
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy to reduce cardiovascular events in high-risk patients: part 2.
    Bommer WJ
    Prev Cardiol; 2008; 11(4):215-22. PubMed ID: 19476574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on the management of atherosclerotic renal artery disease.
    Fenstad ER; Kane GC
    Minerva Cardioangiol; 2009 Feb; 57(1):95-101. PubMed ID: 19202521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM; Böhm M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.